Substantial Cardiovascular Morbidity in Adults With Lower-Complexity Congenital Heart Disease

Priyanka Saha1,2,3, Praneetha Potiny1, Joseph Rigdon4

  • 1Division of Cardiology, Department of Pediatrics (P.S., P.P., M.M., C.T., A.R., S.M.F., D.B.M., D.B., G.K.L., J.R.P.), Stanford University School of Medicine, CA.

Circulation
|March 1, 2019
PubMed

Insights

Adults with lower-complexity congenital heart disease (ACHD) face increased cardiovascular risks, even without traditional risk factors. This highlights the need for closer monitoring and tailored management strategies for this growing patient group.

Area of Science:

  • Cardiology
  • Public Health
  • Genetics

Background:

  • Lower-complexity congenital heart disease (ACHD) is common in adults but its long-term cardiovascular risks are poorly understood.
  • Conventional cardiovascular risk factors do not fully explain the adverse event burden in ACHD patients.

Purpose of the Study:

  • To quantify the risk of adverse cardiovascular events in adults with lower-complexity ACHD.
  • To determine if ACHD poses risks independent of conventional cardiovascular risk factors.

Main Methods:

  • Utilized UK Biobank data from over 500,000 British adults.
  • Employed a classification algorithm to identify individuals with and without lower-complexity ACHD (isolated aortic valve, noncomplex defects).
  • Conducted time-to-event analyses over 22 years for major adverse cardiovascular events, adjusting for 12 cardiovascular risk factors.

Main Results:

  • 2006 individuals with lower-complexity ACHD were identified.
  • ACHD was strongly associated with increased risk of acute coronary syndrome (HR 2.0) and heart failure (HR 13.0), independent of measured risk factors.
  • ACHD patients with ≤2 risk factors had a 29% incidence of major adverse cardiovascular events, compared to 13% in non-ACHD individuals with ≥5 risk factors.

Conclusions:

  • Lower-complexity ACHD significantly increases the burden of adverse cardiovascular events beyond conventional risk factors.
  • There is a critical need for enhanced surveillance and further research into unique risk mechanisms for adults with ACHD.
  • These findings underscore the importance of specialized care for this growing high-risk population.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
475
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
510
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
348
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
324
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
570